Patients & CaregiversHealthcare ProfessionalsWorldwide
HomeAbout MerckProductsNewsroomInvestor RelationsCareersResearchLicensingThe Merck Manuals
THE MERCK MANUAL MEDICAL LIBRARY: The Merck Manual of Diagnosis and Therapy
Tips for better results
ABCDEFGHI
JKLMNOPQR
STUVWXYZ

Section

Subject

Topics

Retinitis Pigmentosa

Update Me

Retinitis pigmentosa is a slowly progressive, bilateral degeneration of the retina and the pigmented epithelium of the choroid. The condition is of incompletely understood genetic origin. Symptoms include night blindness and altered visual fields. Diagnosis is by funduscopic findings, such as dark pigmentation in a bone-spicule configuration in the equatorial retina, narrowed retinal arteries, a waxy yellow disk, degenerative vitreous opacities, cataracts, and myopia. Electroretinography aids in the differential diagnosis. No effective treatment exists.

Abnormal gene coding for retinal proteins appears to be the cause of retinitis pigmentosa. The hereditary pattern is unclear. In most cases it appears to be autosomal recessive but may also be autosomal dominant or, infrequently, X-linked. It may occur as part of a syndrome (eg, Bassen-Kornzweig, Laurence-Moon).

Symptoms, Signs, and Diagnosis

The retinal rods are affected, producing defective night vision that may become symptomatic in early childhood. A mid-peripheral ring scotoma (detectable by visual field testing) widens gradually, so that central vision eventually is reduced.

The most conspicuous funduscopic finding is dark pigmentation in a bone-spicule configuration in the equatorial retina. The retinal arteries appear narrowed, the macula may develop cystic edema, and the disk may have a waxy yellow appearance. Other manifestations can include degenerative vitreous opacities, cataract, and myopia. Congenital hearing loss may be associated.

Diagnosis may be aided by specialized testing (eg, dark adaptation, electroretinography). Other retinopathies that can simulate retinitis pigmentosa (eg, those associated with syphilis, rubella, and phenothiazine or chloroquine Some Trade Names
ARALEN
Click for Drug Monograph
toxicity) must be ruled out. Family members should be examined as necessary to establish the hereditary mode. Families with a history of a hereditary syndrome may wish to seek genetic counseling and may desire testing of family members.

Treatment

No treatment slows the course of the retinal degeneration. Vision loss is typically slow but relentless. Vision drops as the macula becomes increasingly involved and usually evolves to legal blindness.

Last full review/revision November 2005

Content last modified November 2005

Back to Top

Previous: Retinal Detachment

Audio
Figures
Photographs
Tables
Videos
Contact UsSite MapPrivacy PolicyTerms of UseCopyright 1995-2007 Merck & Co., Inc.